Loading...
XSHE
300412
Market cap336mUSD
Oct 09, Last price  
4.54CNY
1D
0.22%
1Q
8.61%
Jan 2017
-52.52%
IPO
73.09%
Name

Zhejiang Canaan Technology Ltd

Chart & performance

D1W1MN
XSHE:300412 chart
P/E
76.24
P/S
1.84
EPS
0.06
Div yield, %
1.32%
Shrs. gr., 5y
1.56%
Rev. gr., 5y
3.05%
Revenues
1.23b
-10.98%
138,210,327152,084,830154,249,253183,810,026217,418,447301,792,829445,032,263578,756,391703,164,5451,007,249,1681,059,613,8691,059,613,8671,103,431,0121,103,431,0121,047,093,8901,383,110,5391,231,257,670
Net income
30m
-18.27%
33,635,21536,214,95834,719,43042,762,13851,454,25257,040,40943,963,93133,632,54951,314,23267,905,49873,697,37573,697,3800-75,201,419-23,433,46836,266,97829,641,856
CFO
190m
+59.06%
21,190,07733,814,27920,846,95038,900,44139,955,51024,678,9080041,507,67555,469,48875,025,26268,616,352-53,646,586119,463,611190,024,189
Dividend
Jun 01, 20260.058 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Zhejiang Canaan Technology Co., Ltd. is a Chinese enterprise specializing in the design, production, and sale of advanced pharmaceutical machinery. Its extensive product portfolio caters broadly to the pharmaceutical industry, particularly within the Oral Solid Dosage (OSD) segment. This includes essential equipment such as dispensing units, high shear mixers, roller compactors, fluid beds, mills, pelleting and coating machines, tablet presses, capsule fillers, and various associated components like pharma lifters, washing machines, and pharma bins. Beyond OSD, Canaan Technology also supplies specialized solutions including OEB equipment, isolators, machinery for research and development, API production systems, packaging solutions, water purification systems, extraction and reactor units, and warehouse logistics products. The company's core clientele operates within the pharmaceutical industry. Established in 2000, Zhejiang Canaan Technology maintains its corporate headquarters in Wenzhou, China.

Key people

Hu Chao
Vice President, Secretary of the Board, Director · since 2024
Zheng Fang
Chairman of the Board, President · since 2024
Zhiyi Fang
Vice Chairman of the Board
Binbin Huang
Director · since 2024
Haizhi Xu
Chief Financial Officer, Director · since 2024
Zhendao Zhou
Director · since 2024
Dezhu Fan
Independent Director · since 2022
Xiaoming Xu
Independent Director · since 2024
Gaoli Zheng
Independent Director · since 2024
IPO date
Dec 31, 2014
Employees
Domiciled in
CN
Incorporated in
CN
Headquarters & legal address
浙江省温州市永嘉县瓯北镇东瓯工业园区
温州市, ZJ 310000
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122022‑002021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT